BSA
ALB icon

Braun Stacey Associates’s Albemarle ALB Stock Holding History

Braun Stacey Associates’s Portfolio ALB Stock Details ALB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-4,250
Closed -$235K – 150
2015
Q2 		$235K Buy
+4,250
New +$254K 0.01% 293

Other funds holding ALB

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GCM
Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Braun Stacey Associates's ALB Position: Q3 2015 in Review

Braun Stacey Associates sold out of Albemarle (ALB) in Q3 2015, closing a stake of 4,250 shares — an estimated $235K sold.

Braun Stacey Associates first reported a position in ALB in Q2 2015 and held it in 1 quarter. The position peaked at $235K in Q2 2015. 303 funds tracked by Wall St. Rank hold ALB as of Q3 2015.

  • Braun Stacey Associates reported no remaining Albemarle position as of Q3 2015 after selling out during the quarter.
  • Braun Stacey Associates sold 4,250 Albemarle shares in Q3 2015, an estimated $235K.
  • Braun Stacey Associates first reported a position in Albemarle in Q2 2015 and held it in 1 quarter.
  • Braun Stacey Associates's Albemarle position peaked at $235K in Q2 2015.
  • 303 funds tracked by Wall St. Rank held Albemarle as of Q3 2015.

Based on Braun Stacey Associates's 13F filing for Q3 2015, filed 1 Dec 2015.